Abstract
Goals of work
The aim of the present study was to evaluate the effects of the intensive dental care protocol in preventing oral complications in acute leukemia patients.
Patients and methods
Thirty-four patients hospitalized for induction remission therapy for acute leukemia were randomly assigned to one of two groups, whether to receive intensive dental care protocol or not. The intensive dental care group of patients received dental treatment and plaque and calculus removal prior to chemotherapy and supervised oral hygiene measures during chemotherapy. The limited dental care group of patients did not receive prechemotherapy dental care. Groups were comparable in age, sex, and antineoplastic treatment received. Patients were examined after admission to the hospital; at the initiation of the chemotherapy; and 7, 14, 21, and 28 days after initiation of therapy. Positive data about subjective difficulties were taken by anamnesis. Oral hygiene index (OHI) and gingival index (GI) were used to assess the periodontal status of the patients. The severity of mucositis was evaluated according to WHO classification.
Main results
The results of this study pointed out lower mean values of GI and lower mean values of mucositis score in the intensive dental care group of patients during the whole period of examination. Although the differences in mean values were not statistically significant on most of the examination days, intensive dental care group of patients developed less severe and less painful oral complications compared to the limited dental care group of patients.
Conclusion
We conclude that proper dental care and preventive measures both before and during chemotherapy can be beneficial to these patients.
Similar content being viewed by others
References
Addy M, Jenkins S, Newcombe R (1991) The effect of some chlorhexidine-containing mouthrinses on salivary bacterial counts. J Clin Periodontol 18:90–93
Barrett PA (1987) A long-term prospective clinical study of oral complications during conventional chemotherapy for acute leukemia. Oral Surg Oral Med Oral Pathol 63:313–316
Barkvoll P, Attramadal A (1989) Effect of nystatin and chlorhexidine digluconate on Candida albicans. Oral Surg Oral Med Oral Pathol 67:279–281
Beighton D, Decker J, Homer KA (1991) Effect of chlorhexidine on proteolytic and glycosidic enzyme activities of dental plaque bacteria. J Clin Periodontol 18:85–89
Bergmann OJ (1988) Oral infections and septicemia in immunocompromised patients with hematologic malignancies. J Clin Microbiol 26:2105–2109
Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, Guerin J, Bergeron C, LeGall E (1998) Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. Eur J Cancer 34(10):1588–1591
Borowski B, Benhamou E, Pico J, Laplanche A, Margainaud J, Hayat M (1994) Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 30B:93–97
Cheng KK, Molassiotis A, Chang AM, Wai WC, Cheung SS (2001) Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer 37:2056–2063
Ellegaard B, Bergmann OJ, Ellegaard J (1989) Effect of plaque removal on patients with acute leukemia. J Oral Pathol Med 18:54–58
Elting LS, Bodey GP, Keefe BH (1992) Septicemia and shock syndrome due to viridans streptococci: a case control study of predisposing factors. Clin Infect Dis 14:1201–1207
Epstein JB, Vickars L, Spinelli J, Reece D (1992) Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol 73(6):682–689
Ferreti GA, Raybould TP, Brown AT, Macdonald JS, Greenwood M, Maruyama Y, Geil J, Lillich T. Ash RC (1990) Chlorhexidine prophylaxis for chemotherapy and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg Oral Med Oral Pathol 69:331–338
Heimdahl A, Mattson T, Dahllof G, Lonnquist B, Ringden O (1989) The oral cavity as port of entry for early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 68:711–716
Hou GL, Huang JS, Tsai CC (1997) Analysis of oral manifestations of leukemia: a retrospective study. Oral Dis 3:31–38
Jankoviç L, Jeliç S, Filipoviç-Lješkoviç I, Ristoviç Z (1995) Salivary immunoglobulins in cancer patients with chemotherapy-related oral mucosa damage. Oral Oncol Eur J Cancer 31B(3):160–165
Khan SA, Wingard JR (2001) Infection and mucosal injury in cancer treatment. NCI Monogr 29:31–36
Labar B, Mršiç M, Pavletiç Z et al (1993) Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transplant 11(5):379–382
Laine PO, Lindqvist JC, Pyrhonen SO, Strand-Pettinen IM, Teerenhovi LM, Muerman JH (1992) Oral infection as a reason for febrile episodes in lymphoma patients receiving cytostatic drugs. Oral Oncol Eur J Cancer 28B(2):103–107
Levy-Polack MP, Sebelli P, Polack NL (1998) Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec Care Dent 18:189–193
National Institutes of Health (1990) Consensus development conference on oral complications of cancer therapies: consensus statement. NCI Monogr 9
Peterson DE, Minah GE, Overholser CD, Suzuki JB, DePaola LG, Stansbury DM, Williams LT, Schimpff SC (1987) Microbiology of acute periodontal infection in myelosuppressed cancer patients. J Clin Oncol 5:1461–1468
Peterson DE, Minah GE, Reynolds MA, Weikel DS, Overholser CD, DePaola LG, Wade JC, Suzuki JB (1990) Effect of granulocytopenia on oral microbial relationships in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 70:720–723
Peterson DE (1990) Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr 9:61–71
Pico JL, Avila-Garavito A, Naccache P (1998) Mucositis: its occurrence, consequences, and treatment in oncology setting. Oncologist 3(6):446–451
Rubenstein EB, Peterson DE, Schubert M, Deborah McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9):2026–2046
Rutkauskas JS, Davis JW (1993) Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report. Oral Surg Oral Med Oral Pathol 76:441–448
Sonis S, Kunz A (1988) Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies. Oral Surg Oral Med Oral Pathol 65:19–22
Sonis ST, Elting LS, Keefe, Peterson DE, Schubert M, Hauer-Jensen M, Nebiyou Bekele B, Raber-Durlacher J, Peter Donnelly J, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury. Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9):1995–2025
Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4(4):277–284
Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVegue FG, Miller C, Peterson DE, Schubert MM, Spijkervet FKL, Horowitz M (2001) Oral mucositis and economic outcomes of hematopoetic stem-cell transplantation. J Clin Oncol 19(8):2201–2205
Spijkervet FKL, van Saene JJM, van Saene HKF et al (1990) Chlorhexidine inactivation by saliva. Oral Surg Oral Med Oral Pathol 69:444–449
Tolo K (1991) Periodontal disease mechanisms in immunocompromised patients. J Clin Periodontol 18:431–435
Wahlin YB (1989) Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 68:279–287
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Djuric, M., Hillier-Kolarov, V., Belic, A. et al. Mucositis prevention by improved dental care in acute leukemia patients. Support Care Cancer 14, 137–146 (2006). https://doi.org/10.1007/s00520-005-0867-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-005-0867-7